Scandinavian ChemoTech
4,63 SEK +2,21 %Vær den første som følger denne virksomhed
Scandinavian ChemoTech is a research and development company that has developed the technology Tumor-Specific Electroporation - TSE ™ for the treatment of various cancers. The technology means that electronic pulses are sent to the treated area and the membranes of the tumor cells are opened to reach their DNA. In addition to its operations in Sweden, the company is also active in Southeast Asia and India. Scandinavian ChemoTech was founded in 2015 and is headquartered in Lund.
Omsætning
470 t
EBIT %
-4.448,94 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
CMOTEC B
Daglig lav / høj pris
4,34 / 4,63
SEK
Markedsværdi
56,51 mio. SEK
Aktieomsætning
38,88 t SEK
Volumen
8,7 t
Finanskalender
Delårsrapport
15.08.2023
Delårsrapport
07.11.2023
Årsrapport
05.03.2024
Viser Alle indholdstyper